MRI study of heart involvement in Wilson disease
Part of Brain & nervous system, Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at whether Wilson disease affects the heart, using MRI scans (and possibly contrast dye). Your results may help doctors better understand cardiac (heart) involvement and how it progresses in Wilson disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult with confirmed Wilson disease (Leipzig score 4 or higher)
- You can consent to the study (or your legal guardian/curator can, if applicable)
- You are covered by a Social Security program (member or beneficiary)
- You can safely have MRI scans, including if contrast dye is needed
- You are not pregnant or breastfeeding (pregnancy testing may be required)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how much copper is present in breast milk in people with Wilson’s disease. It aims to provide safer guidance for breastfeeding during treatment, including during pregnancy.
This study looks for early signs of heart problems in people with Wilson's disease. It uses imaging tests to check the heart, which may help catch issues early.
This study follows people who have the genetic cause of Wilson disease, including people who feel well and family members. Researchers want to better understand Wilson disease and what to watch for over time.
This trial is testing an experimental gene therapy called PM577 that aims to fix the faulty gene causing Wilson disease. It might offer a new treatment option that could reduce or replace the need for daily medications.
This trial is a patient registry that collects health information from people with Wilson’s disease, including those without symptoms yet and those taking any type of treatment. It helps researchers understand the disease and how it progresses, which can support future studies and care improvements.
This early-stage trial tests LY-M003, a new gene therapy treatment for Wilson's disease—a rare genetic condition where copper builds up in the body. The study aims to see if this injection is safe and whether it can help patients who are already on standard copper-lowering medicines.
Hear when a new Wilson's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.